• ホーム
  • 検索結果
  • Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2.

Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (2014-07-26)
Janet M C Ngu, Guoqi Teng, Hans Christopher Meijndert, Holly E Mewhort, Jeannine D Turnbull, William G Stetler-Stevenson, Paul W M Fedak
要旨

Tissue inhibitor of metalloproteinase-2 (TIMP-2) is an endogenous inhibitor of matrix metalloproteinases (MMPs) that attenuates maladaptive cardiac remodeling in ischemic heart failure. We examined the effects of TIMP-2 on human cardiac fibroblast activation and extracellular matrix (ECM) remodeling. Human cardiac fibroblasts within a three-dimensional collagen matrix were assessed for phenotype conversion, ECM architecture and key molecular regulators of ECM remodeling after differential exposure to TIMP-2 and Ala+TIMP-2 (a modified TIMP-2 analogue devoid of MMP inhibitory activity). TIMP-2 induced opposite effects on human cardiac fibroblast activation and ECM remodeling depending on concentration. TIMP-2 activated fibroblasts into contractile myofibroblasts that remodeled ECM. At higher concentrations (>10 nM), TIMP-2 inhibited fibroblast activation and prevented ECM remodeling. As compared to profibrotic cytokine transforming growth factor (TGF)-beta1, TIMP-2 activated fibroblasts and remodeled ECM without a net accumulation of matrix elements. TIMP-2 increased total protease activity as compared to TGF-beta1. Ala+TIMP-2 exposure revealed that the actions of TIMP-2 on cardiac fibroblast activation are independent of its effects on MMP inhibition. In the presence of GM6001, a broad-spectrum MMP inhibitor, TIMP-2-mediated ECM contraction was completely abolished, indicating that TIMP-2-mediated fibroblast activation is MMP dependent. TIMP-2 functions in a contextual fashion such that the effect on cardiac fibroblasts depends on the tissue microenvironment. These observations highlight potential clinical challenges in using TIMP-2 as a therapeutic strategy to attenuate postinjury cardiac remodeling.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
トリパンブルー 溶液, 0.4%, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
トリパンブルー, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
トリパンブルー 溶液, 0.4%, for microscopy
Sigma-Aldrich
N-(3-アミノプロピル)メタクリルアミド 塩酸塩, contains ≤1,000 ppm MEHQ as stabilizer, 98% (HPLC)
Sigma-Aldrich
酢酸4-アミノフェニル水銀, ≥90% (titration)
Sigma-Aldrich
トリパンブルー, Dye content 60 %
Sigma-Aldrich
MMP-2 ヒト, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
Matrix Metalloproteinase-2 ヒト, >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
Sigma-Aldrich
TIMP-2 ヒト, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture
Sigma-Aldrich
抗VIM ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
ANTI-DDR2 (TYRO10) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
抗ビメンチン ウサギ宿主抗体, affinity isolated antibody
Sigma-Aldrich
抗ビメンチン ウサギ宿主抗体, affinity isolated antibody
Sigma-Aldrich
Anti-TYRO10 antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
Sigma-Aldrich
Anti-TYRO10 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-VIM (AB1) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Rabbit anti-Vimentin Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.

ソーシャルメディア

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

研究、開発、製造

私たちは、バイオテクノロジーと医薬品の研究&開発および製造のソリューションとサービスを提供する、グローバルなライフサイエンス業界のリーディングサプライヤーです。

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates.All Rights Reserved.

当ウェブサイトのいかなる内容についても、許可なく複写することを禁じます。